Paul E. de Jong

38.2k total citations · 9 hit papers
311 papers, 24.9k citations indexed

About

Paul E. de Jong is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Paul E. de Jong has authored 311 papers receiving a total of 24.9k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Nephrology, 128 papers in Cardiology and Cardiovascular Medicine and 47 papers in Surgery. Recurrent topics in Paul E. de Jong's work include Chronic Kidney Disease and Diabetes (115 papers), Blood Pressure and Hypertension Studies (90 papers) and Dialysis and Renal Disease Management (83 papers). Paul E. de Jong is often cited by papers focused on Chronic Kidney Disease and Diabetes (115 papers), Blood Pressure and Hypertension Studies (90 papers) and Dialysis and Renal Disease Management (83 papers). Paul E. de Jong collaborates with scholars based in Netherlands, United States and Pakistan. Paul E. de Jong's co-authors include Dick de Zeeuw, Ron T. Gansevoort, Kunihiro Matsushita, Josef Coresh, Andrew S. Levey, Brad C. Astor, Hans L. Hillege, Stephan J. L. Bakker, Mark Woodward and Marije van der Velde and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Paul E. de Jong

306 papers receiving 24.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

2010 3.0k citations Paul E. de Jong et al. profile →
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report

2010 1.7k citations Paul E. de Jong, Ron T. Gansevoort et al. Kidney International profile →
Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population

2002 1.2k citations Hans L. Hillege, Gilles F.H. Diercks et al. Circulation profile →
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

2012 976 citations Hiddo J.L. Heerspink, Marcello Tonelli et al. profile →
Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis

2003 775 citations Paul E. de Jong, Dick de Zeeuw et al. profile →
Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement

2004 759 citations Jacobien C. Verhave, Hans L. Hillege et al. Kidney International profile →
Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts

2011 610 citations Ron T. Gansevoort, Paul E. de Jong et al. Kidney International profile →
Trimethoprim–Sulfamethoxazole (Co-Trimoxazole) for the Prevention of Relapses of Wegener's Granulomatosis

1996 538 citations Coen A. Stegeman, Paul E. de Jong et al. profile →
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

2011 533 citations Ron T. Gansevoort, Paul E. de Jong et al. Kidney International profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul E. de Jong Netherlands	73	13.0k	8.6k	4.4k	4.1k	3.2k	311	24.9k
Mark J. Sarnak United States	81	16.4k 1.3×	9.0k 1.1×	2.7k 0.6×	4.2k 1.0×	3.9k 1.2×	288	27.9k
Julia B. Lewis United States	46	11.5k 0.9×	10.1k 1.2×	7.2k 1.7×	4.2k 1.0×	3.9k 1.2×	117	27.2k
Brad C. Astor United States	70	14.7k 1.1×	7.4k 0.9×	3.5k 0.8×	5.3k 1.3×	4.0k 1.2×	299	28.9k
Michael G. Shlipak United States	93	15.2k 1.2×	10.7k 1.3×	2.9k 0.7×	4.7k 1.1×	4.2k 1.3×	544	33.0k
Yaping Zhang China	30	11.4k 0.9×	6.9k 0.8×	3.5k 0.8×	4.3k 1.0×	3.9k 1.2×	200	28.3k
Chi‐yuan Hsu United States	57	13.8k 1.1×	5.8k 0.7×	2.5k 0.6×	3.9k 0.9×	3.5k 1.1×	202	23.2k
Alejandro Castro Spain	18	8.2k 0.6×	5.0k 0.6×	2.8k 0.6×	3.1k 0.8×	3.0k 0.9×	62	20.5k
Ron T. Gansevoort Netherlands	69	9.8k 0.8×	6.0k 0.7×	4.3k 1.0×	3.5k 0.8×	2.7k 0.9×	463	23.9k
Kunihiro Matsushita United States	70	10.3k 0.8×	9.8k 1.1×	5.3k 1.2×	4.0k 1.0×	4.5k 1.4×	506	27.6k
Adeera Levin Canada	69	19.1k 1.5×	6.0k 0.7×	3.2k 0.7×	5.0k 1.2×	5.1k 1.6×	418	33.2k

Countries citing papers authored by Paul E. de Jong

Since Specialization

Citations

This map shows the geographic impact of Paul E. de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul E. de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul E. de Jong more than expected).

Fields of papers citing papers by Paul E. de Jong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul E. de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul E. de Jong. The network helps show where Paul E. de Jong may publish in the future.

Co-authorship network of co-authors of Paul E. de Jong

This figure shows the co-authorship network connecting the top 25 collaborators of Paul E. de Jong. A scholar is included among the top collaborators of Paul E. de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul E. de Jong. Paul E. de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boertien, Wendy E., Esther Meijer, Paul E. de Jong, et al.. (2015). Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function. American Journal of Kidney Diseases. 65(6). 833–841. 66 indexed citations

Forman, John P., Lieneke Scheven, Paul E. de Jong, et al.. (2012). Association Between Sodium Intake and Change in Uric Acid, Urine Albumin Excretion, and the Risk of Developing Hypertension. Circulation. 125(25). 3108–3116. 77 indexed citations

Turin, Tanvir Chowdhury, Joseph Coresh, Marcello Tonelli, et al.. (2012). Short-term change in kidney function and risk of end-stage renal disease. Nephrology Dialysis Transplantation. 27(10). 3835–3843. 83 indexed citations

Halbesma, Nynke, Désirée F. Jansen, Martijn W. Heymans, et al.. (2011). Development and Validation of a General Population Renal Risk Score. Clinical Journal of the American Society of Nephrology. 6(7). 1731–1738. 65 indexed citations

Meijer, Esther, R. T. Gansevoort, Paul E. de Jong, et al.. (2011). Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug. Nephrology Dialysis Transplantation. 26(8). 2445–2453. 60 indexed citations

Özyilmaz, Akin, et al.. (2010). Selection on albuminuria enhances the efficacy of screening for cardiovascular risk factors. Nephrology Dialysis Transplantation. 25(11). 3560–3568. 15 indexed citations

Jong, Paul E. de, et al.. (2010). Comparison of the yield of different screening approaches to detect chronic kidney disease. Nephrology Dialysis Transplantation. 25(10). 3222–3230. 15 indexed citations

Halbesma, Nynke, Stephan J. L. Bakker, Désirée F. Jansen, et al.. (2009). High Protein Intake Associates with Cardiovascular Events but not with Loss of Renal Function. Journal of the American Society of Nephrology. 20(8). 1797–1804. 77 indexed citations

Oterdoom, Leendert H., Aiko P. J. de Vries, Rutger M. van Ree, et al.. (2009). N-Terminal Pro-B-Type Natriuretic Peptide and Mortality in Renal Transplant Recipients Versus the General Population. Transplantation. 87(10). 1562–1570. 60 indexed citations

10.

Dasselaar, Judith J., Marjolijn N. Lub–de Hooge, Jan Pruim, et al.. (2007). Relative Blood Volume Changes Underestimate Total Blood Volume Changes during Hemodialysis. Clinical Journal of the American Society of Nephrology. 2(4). 669–674. 61 indexed citations

11.

Brinkman, Jacoline, Dick de Zeeuw, Hiddo J.L. Heerspink, et al.. (2007). Apparent Loss of Urinary Albumin during Long-term Frozen Storage: HPLC vs Immunonephelometry. Clinical Chemistry. 53(8). 1520–1526. 34 indexed citations

12.

Ree, Rutger M. van, Leendert H. Oterdoom, Aiko P. J. de Vries, et al.. (2006). Elevated levels of C-reactive protein independently predict accelerated deterioration of graft function in renal transplant recipients. Nephrology Dialysis Transplantation. 22(1). 246–253. 57 indexed citations

13.

Mei, Sijrike F. van der, et al.. (2006). Social participation after successful kidney transplantation. Disability and Rehabilitation. 29(6). 473–483. 30 indexed citations

14.

Boersma, Cornelis, Jarir At Thobari, Ron T. Gansevoort, et al.. (2006). Pharmacoeconomics of Angiotensin II Antagonists in Type 2 Diabetic Patients with Nephropathy. PharmacoEconomics. 24(6). 523–535. 21 indexed citations

15.

Hillege, Hans L., Jacobien C. Verhave, Stephan J. L. Bakker, et al.. (2004). 1159-194 Cystatin C, a novel risk marker for mortality in the general population: Data obtained from the PREVEND study. Journal of the American College of Cardiology. 43(5). A519–A519. 2 indexed citations

16.

Verhave, Jacobien C., Ron T. Gansevoort, Hans L. Hillege, et al.. (2004). Drawbacks of the use of indirect estimates of renal function to evaluate the effect of risk factors on renal function.. University of Groningen research database (University of Groningen / Centre for Information Technology). 15(5). 1316–22. 61 indexed citations

17.

Brinkman, Jacoline, Stephan J. L. Bakker, Ron T. Gansevoort, et al.. (2004). Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLC. Kidney International. 66(92). S69–S75. 64 indexed citations

18.

Diercks, Gilles F.H., et al.. (2002). The importance of microalbuminuria as a cardiovascular risk indicator: A review.. University of Groningen research database (University of Groningen / Centre for Information Technology). 18(5). 525–35. 60 indexed citations

19.

Stegeman, Coen A., et al.. (1999). Assessing dialysis adequacy and dietary intake in the individual hemodialysis patient. Kidney International. 55(5). 1961–1969. 60 indexed citations

20.

Gameren, Ingrid I. van, et al.. (1994). Concurrent Presentation of Hemolytic Uremic Syndrome in Two Adult Siblings: Effects of Plasma Therapy on Hemolysis and Renal Function. American Journal of Nephrology. 14(1). 67–71. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact